26 Recruiting Melanoma Phase 1 Clinical Trials
Active phase 1 studies for melanoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Melanoma studiesPhase 1 Studies for Melanoma
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
📍 The Angeles Clinic and Research Institute - California — Los Angeles, California
View Study & Checklist ➔A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
📍 Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.
📍 California Pacific Medical Center Research Institute — San Francisco, California
View Study & Checklist ➔Transfer of Genetically Engineered Lymphocytes in Melanoma Patients
📍 Loyola University Medical Center — Maywood, Illinois
View Study & Checklist ➔A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
📍 Duke Cancer Center — Durham, North Carolina
View Study & Checklist ➔XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)
📍 London Regional Cancer Program — London, Ontario
View Study & Checklist ➔A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
📍 GSK Investigational Site — Los Angeles, California
View Study & Checklist ➔Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
📍 University of Chicago Medical Center — Chicago, Illinois
View Study & Checklist ➔Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
📍 Call for Information (Investigational Site 0019) — Aurora, Colorado
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
📍 The Kirklin Clinic of UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
📍 James Graham Brown Cancer Center-University of Louisville — Louisville, Kentucky
View Study & Checklist ➔RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
📍 Loyola University Medical Center — Maywood, Illinois
View Study & Checklist ➔A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
📍 Research Site — Grand Rapids, Michigan
View Study & Checklist ➔A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
📍 Arizona Cancer Center at UMC North/University Medical Center — Tucson, Arizona
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
View Study & Checklist ➔MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer
📍 Sunnybrook Health Sciences Centre — Toronto, Ontario
View Study & Checklist ➔